| 1 |
32860356 | Pharmacokinetic characterization of fluorocoxib D, a cyclooxygenase-2-targeted optical imaging agent for detection of cancer. | 2020 Aug |
1 |
| 2 |
30110616 | Intradiscal delivery of celecoxib-loaded microspheres restores intervertebral disc integrity in a preclinical canine model. | 2018 Sep 28 |
1 |
| 3 |
25571853 | Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms. | 2015 Mar |
3 |
| 4 |
24503782 | Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors. | 2014 Apr |
1 |
| 5 |
24656746 | Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines. | 2014 Jun |
3 |
| 6 |
19955429 | Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. | 2010 Jan 5 |
1 |
| 7 |
17244169 | Effects of cyclooxygenase-2 inhibitor on glucagon-induced delayed gastric emptying and gastric dysrhythmia in dogs. | 2007 Feb |
3 |
| 8 |
12384079 | Celecoxib (celebrex) increases canine lower esophageal sphincter pressure. | 2002 Sep |
2 |
| 9 |
10497139 | Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. | 1999 Oct |
2 |